Predicted protein targets (top 13)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | KDM4E | B2RXH2 | 1/20 | 0.36 |
| ▸ | ATM | Q13315 | 1/20 | 0.36 |
| ▸ | L3MBTL1 | Q9Y468 | 1/20 | 0.36 |
| ▸ | SMN1; SMN2 | Q16637 | 3/20 | 0.32 |
| ▸ | LMNA | P02545 | 1/20 | 0.32 |
| ▸ | NPSR1 | Q6W5P4 | 2/20 | 0.31 |
| ▸ | AHR | P35869 | 1/20 | 0.30 |
| ▸ | PTGER4 | P35408 | 2/20 | 0.30 |
| ▸ | CA12 | O43570 | 1/20 | 0.30 |
| ▸ | CA9 | Q16790 | 1/20 | 0.30 |
| ▸ | ALDH1A1 | P00352 | 1/20 | 0.30 |
| ▸ | CYP1A2 | P05177 | 1/20 | 0.30 |
| ▸ | CYP2C9 | P11712 | 1/20 | 0.30 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL24163262 | 0.97 | KDM4E (0.37) | KDM4EATML3MBTL1SMN1; SMN2LMNA | |
| SCHEMBL24800909 | 0.97 | KDM4E (0.35) | KDM4EATML3MBTL1SMN1; SMN2LMNA | |
| SCHEMBL25965896 | 0.96 | KDM4E (0.36) | KDM4EATML3MBTL1SMN1; SMN2LMNA | |
| SCHEMBL24078494 | 0.96 | KDM4E (0.36) | KDM4EATML3MBTL1SMN1; SMN2LMNA | |
| SCHEMBL19769905 | 0.95 | KDM4E (0.34) | KDM4EATML3MBTL1SMN1; SMN2LMNA | |
| SCHEMBL25965883 | 0.95 | KDM4E (0.35) | KDM4EATML3MBTL1SMN1; SMN2LMNA | |
| SCHEMBL23602246 | 0.95 | KDM4E (0.38) | KDM4EATML3MBTL1SMN1; SMN2LMNA | |
| SCHEMBL25965873 | 0.94 | KDM4E (0.35) | KDM4EATML3MBTL1SMN1; SMN2LMNA | |
| SCHEMBL25965894 | 0.94 | KDM4E (0.35) | KDM4EATML3MBTL1SMN1; SMN2LMNA | |
| SCHEMBL19769906 | 0.94 | KDM4E (0.33) | KDM4EATML3MBTL1SMN1; SMN2LMNA |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 5 patents. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| US-20230284526-A1 | ORGANIC ELECTROLUMINESCENT ELEMENT | NIPPON STEEL CHEMICAL & MATERIAL CO., LTD. (JP) | 2023-09-07 | — | — | US | disclosed |
| US-20230284526-A1 | ORGANIC ELECTROLUMINESCENT ELEMENT | NIPPON STEEL CHEMICAL & MATERIAL CO., LTD. (JP) | 2023-09-07 | — | — | US | disclosed |
| US-20230131577-A1 | ORGANIC ELECTROLUMINESCENT ELEMENT | NIPPON STEEL CHEMICAL & MATERIAL CO., LTD. (JP) | 2023-04-27 | — | — | US | disclosed |
| US-20230131577-A1 | ORGANIC ELECTROLUMINESCENT ELEMENT | NIPPON STEEL CHEMICAL & MATERIAL CO., LTD. (JP) | 2023-04-27 | — | — | US | disclosed |
| US-20220416177-A1 | ORGANIC ELECTROLUMINESCENT ELEMENT AND METHOD FOR MANUFACTURING SAME | NIPPON STEEL CHEMICAL & MATERIAL CO., LTD. (JP) | 2022-12-29 | — | — | US | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (2 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20230131577-A1 | ORGANIC ELECTROLUMINESCENT ELEMENT | LEF1, EPB41, EPB41L2 | KDM4E 1097/4885ATM 3975/4885L3MBTL1 877/4885 |
| US-20220416177-A1 | ORGANIC ELECTROLUMINESCENT ELEMENT AND METHOD FOR MANUFACTURING SAME | NR4A3, NR4A1, NR4A2 | KDM4E 594/4885ATM 4358/4885L3MBTL1 532/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.